HighTower Advisors
CMD

HighTower Advisors’s Cantel Medical Corporation CMD Stock Holding History

HighTower Advisors’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-500
Closed -$900K – 2083
2016
Q1 		$900K Buy
+500
New +$31.4K ﹤0.01% 1086

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

HighTower Advisors's CMD Position: Q4 2017 in Review

HighTower Advisors sold out of Cantel Medical Corporation (CMD) in Q4 2017, closing a stake of 3,056 shares — an estimated $287K sold.

HighTower Advisors first reported a position in CMD in Q1 2016 and held it in 4 quarters. The position peaked at $386K in Q3 2016. 245 funds tracked by Wall St. Rank hold CMD as of Q4 2017.

  • HighTower Advisors reported no remaining Cantel Medical Corporation position as of Q4 2017 after selling out during the quarter.
  • HighTower Advisors sold 3,056 Cantel Medical Corporation shares in Q4 2017, an estimated $287K.
  • HighTower Advisors first reported a position in Cantel Medical Corporation in Q1 2016 and held it in 4 quarters.
  • HighTower Advisors's Cantel Medical Corporation position peaked at $386K in Q3 2016.
  • 245 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2017.

Based on HighTower Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.